Connect with us

Laws

In Germany, big questions on recreational cannabis legalization still unanswered

Published

on

Germany is forging ahead with plans to establish Europe’s first national recreational cannabis market, but details about the rules that will govern the industry remain scarce.

That has made it more difficult for cannabis industry executives to gauge the potential sales opportunities in Germany.

Once it does launch, will Germany’s billion-euro recreational cannabis market be in the low single digits, the double digits or somewhere in between?

That depends, in part, on answers to these and other questions:

  • When will edibles and vapes be allowed? Years down the road, right off the bat or never?
  • Where will cannabis be sold, how will it be taxed and how many sales outlets will open in the early years?
  • How much will regulatory restrictions, such as capping THC, impair the legal market?
  • If sales start only in pharmacies, how will that retail experience for consumers impact sales?
  • Will marijuana be produced in Germany? So far, no country allows the import/export of recreational cannabis. Will Germany be the first?

Germany’s Ministry of Health is conducting hearings to address some of those issues.

A draft law is expected to be published this year.

Beyond that, much is unknown.

Constantin von der Groeben, managing director of Berlin-based cannabis company Demecan, said the size of any legal marijuana market in Europe’s largest economy will be difficult to assess until regulatory details are ironed out.

“What is clear, however, is there is a market that already exists and has a meaningful size, which we know from the anti-drug reports,” he said of Germany’s medical cannabis market.

Some CEOs are taking a prudent approach before incorporating potential sales into revenue projections.

“My hope is that the government will take the time needed to get this right, as pushing out a botched regulation is a massive risk to public health and Germany’s reputation as a front-runner on adult-use in Europe,” Oliver Zugel, founder and CEO of Bogota, Colombia-based FoliuMed Holdings, told MJBizDaily.

“Truth is that apart from electoral considerations and misguided industry pressure, there isn’t a real reason to rush this. And it’s better to take small steps which can be corrected later than trying to solve the whole puzzle in one go.”

With so much still up in the air, MJBizDaily asked executives about the pending German marijuana market.

Many countries have talked about legalizing cannabis in some form, but it almost never happens “on schedule” or on time. What are your expectations for Germany?

• Demecan’s von der Groeben: “Originally, we anticipated a draft bill only in 2023. But in the last few weeks it seems that the government wants to use the summer break and the second half of 2022 to actually get at least a first draft done. Ideally, we would then see an approval of the new law in 2023.”

• Niklas Kouparanis, CEO and co-founder, Frankfurt-based Bloomwell Group: “German minister of health, Karl Lauterbach, announced that the draft of the country’s legal adult-use cannabis laws will be completed this year, and drug commissioner, Burkhard Blienert, plans to consult with industry experts to help draft the law.

“This is a clear signal to the market and investors that the government is very serious about legalizing adult-use cannabis in Germany. However, in terms of the timeline, I assume that we will have the legal adult-use market not before Q4 2023 or the beginning of 2024. But what is most important during this process is attention to detail.

“Precision, rather than speed, will help ensure a successful and sustainable market that also includes quality-control measures and regulations to ensure the protection of minors.”

When Germany legalizes cannabis, how do you think it will navigate the United Nations’ Single Convention on Narcotic Drugs (1961) and other international treaty obligations?

Demecan’s von der Groeben: “This is one of the bigger questions to answer. Currently, I think Germany will have to breach the convention at least for some time. This will probably mean that all recreational cannabis must come from within Germany as imports will be restricted.”

Bloomwell’s Kouparanis: “Germany is known for its commitment to regulations and bureaucratic processes, so we may leave and then reenter the U.N. single convention during our process to legalize adult-use cannabis.

“As an alternative, I could also imagine that we follow the ‘Canadian-way’ – ignoring the Single Convention’s prohibition of cannabis.”

How would you like to see Germany regulate sales – at privately owned stores, government-owned stores and wholesalers or in pharmacies?

David Henn, CEO, Cologne-based Cannamedical: “We believe that the most efficient path for a successful legalization is a ‘pharmacy-plus’ model, which has a track record and experience in handling, storing and distributing the products.”

Bloomwell’s Kouparanis: “The overall aim of the government is to guarantee protection of minors, product safety and education by pushing back the illicit market. Therefore, we need a nationwide sales infrastructure. This will not be achieved if we only choose already existing pharmacies; we will definitely need privately owned dispensaries.

“Beyond that, we should also allow e-commerce and online distribution, as all relevant processes to protect minors and educate consumers can be run online. If we don’t allow online sales, we will just push the illicit market to the periphery. Another important lesson learned from Canada: We should not limit the number of dispensaries.

“Also, we should standardize regulations across the country and not have different rules throughout Germany’s 16 states (as is the case in Canada’s 13 jurisdictions).”

Most cannabis businesses, and even analysts, use the wrong definition for “addressable market.” How do you define addressable market?

Demecan’s von der Groeben: “Until we know the details of the regulation of the recreational cannabis market, it is difficult to assess its size. What is clear, however, is that it is a market that already exists and that has a meaningful size, which we know from the anti-drug reports.

“We could therefore start with an estimated number of consumers in the current illicit market and then estimate how many of these consumers would transfer to the legitimate market.”

Germany won’t be able to import recreational cannabis because of international treaty obligations, correct? 

FoliuMed’s Zugel: “I think that’s a big assumption you are making here (on imports not being allowed), and I don’t think it will play out this way.

“Even if this was economically viable and technically feasible – which we think it isn’t – how would a government justify to Green Party voters that electricity consumption will increase by 1%-3% as a result of hundreds of indoor cultivators in the middle of the country’s most pronounced energy crisis?”

Bloomwell’s Kouparanis: “A stable supply is crucial to push back the illicit market. Our economic scientist, Justus Haucap, has estimated a demand of 400 tonnes (annually) once the adult-use market comes online.

“I don’t think that this demand will completely be covered by domestic cultivation. And, who knows, maybe our drug commissioner, Burkhard Blienert, finds a way to make imports possible even within the single convention.

How do you see the future of Germany’s medical cannabis industry? Germany is currently the second-biggest federally regulated medical market, after Canada.

Demecan’s von der Groeben: “I have no doubt that it will become No. 1. We see a constant rise, and more and more health care practitioners are convinced by the positive effects of cannabis. We are now curious to see if, and to what extent, the market will move away from cannabis flower to cannabis extracts or even further licensed cannabis drugs.”

Bloomwell’s Kouparanis: “To make use of the full potential of medical cannabis (in Germany), two things need to change: First, public insurers should no longer have the final word regarding whether they will reimburse medical cannabis for a patient. This decision should only be made by doctors. Secondly, we need more doctors with expertise about our endocannabinoid system.”

The hype in this industry rarely matches what actually happens. In your view, what is a reasonable time frame for other large European countries to fully legalize and regulate the production and sale of recreational cannabis?

Demecan’s von der Groeben: “My guess is that other large EU countries, such as France, Italy or Spain, will follow in Germany’s footsteps.

“Therefore, I expect Germany to legalize recreational cannabis by 2023, and then, a few years later, we will see other countries follow.

“And smaller EU countries might even be faster, such as Poland or Czech Republic.”

These interviews were edited for length and clarity.

Source: https://mjbizdaily.com/big-questions-about-germany-cannabis-legalization-still-unanswered/

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms

Published

on

The Minnesota Supreme Court affirmed that cannabis odor does not constitute probable cause to search a vehicle.

If Minnesota police search a vehicle solely based upon the smell of pot, they can’t justify searching a vehicle, even if there is evidence found of other alleged crimes. Even after appealing a lower court decision to suppress the evidence—twice—the Minnesota Supreme Court agreed, and the dismissal of his charges stands.

In a ruling filed regarding a case the State of Minnesota Court of Appeals on Sept. 13, the Minnesota Supreme Court affirmed that cannabis odor does not constitute probable cause to search a vehicle.

The case has been ongoing for two years. On July 5, 2021, just before 10 p.m., a Litchfield police officer stopped a car for an obscure local law: the light bar mounted on the vehicle’s grill had more auxiliary driving lights than are permitted under Minnesota law. The officer asked the driver, Adam Lloyd Torgerson, for his license and registration. Torgerson, his wife, and his child were present in the vehicle. The officer stated that he smelled pot and asked Torgerson if there was any reason for the odor, which he initially denied. But cops found a lot more than just pot.

A backup officer was called in. The couple denied possessing any pot, but Torgerson admitted to smoking weed in the past. The second officer stated that the weed odor gave them probable cause to search the vehicle and ordered them to exit the vehicle. The first officer searched the vehicle and found a film canister, three pipes, and a small plastic bag in the center console. The plastic bag contained a white powder and the film canister contained meth, which was confirmed in a field test.

Torgenson was charged with possession of meth pipe in the presence of a minor and fifth-degree possession of a controlled substance after the unwarranted search of Torgerson’s vehicle. 

Police Aren’t Allowed to Do That, Multiple Courts Rule

But the search had one major problem—cops weren’t searching for a meth pipe. They only searched his car because they could smell pot, and the meth and paraphernalia were a surprise for everyone. Still, they had no grounds to search the vehicle. The man’s charges were later dismissed after the district court determined the odor of cannabis alone was insufficient basis for probable cause to search the vehicle, regardless of whatever other drug paraphernalia they found. 

The state appealed the case, but the Minnesota Court of Appeals affirmed the district court’s decision. The case was appealed a second time, this time to the Minnesota Supreme Court, which agreed with the lower court’s ruling. 

 “This search was justified only by the odor of marijuana emanating from the vehicle,” the Minnesota Supreme Court decision reads. “Torgerson moved to suppress the evidence found during the search, arguing that the odor of marijuana, alone, is insufficient to create the requisite probable cause to search a vehicle under the automobile exception to the warrant requirement. The district court granted Torgerson’s motion, suppressed the evidence, and dismissed the complaint. The State appealed. The court of appeals affirmed the district court’s suppression order. Because we conclude that the odor of marijuana emanating from a vehicle, alone, is insufficient to create the requisite probable cause to search a vehicle under the automobile exception to the warrant requirement, we affirm.”

It amounts to basic human rights that apply—regardless of whether or not a person is addicted to drugs.

Other States do Precisely the Same Regarding Pot Odor as Probably Cause

An Illinois judge ruled in 2021 that the odor of cannabis is not sufficient grounds for police to search a vehicle without a warrant during a traffic stop.

Daniel J. Dalton, Associate Judge of the 14th Judicial Circuit, issued a ruling in response to a motion to suppress evidence in the case of Vincent Molina, a medical cannabis patient arrested for cannabis possession last year.

In that case, Molina was arrested despite the decriminalization of small amounts of cannabis in Illinois in 2019 with the passage of the Illinois Cannabis Regulation and Tax Act. 

In some states, the issue of probable cause and cannabis was defined through bills.

Last April, the Maryland House of Delegates approved a bill that reduces the penalties for public cannabis consumption and bars police from using the odor of cannabis as the basis for the search of an individual or auto. Under Maryland’s House Bill 1071, law enforcement officers would be prohibited from using the odor of raw or burnt cannabis as probable cause to search a person or vehicle. 

The rulings represent the rights of citizens when they are pulled over by police, even if there are hard drugs involved.

Source: https://hightimes.com/news/pot-odor-does-not-justify-probable-cause-for-vehicle-searches-minnesota-court-affirms/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News